{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:12:32Z","timestamp":1773259952864,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Scientist Development Grant","award":["09SDG2250712"],"award-info":[{"award-number":["09SDG2250712"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.biopha.2015.02.015","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T21:20:30Z","timestamp":1424899230000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus"],"prefix":"10.1016","volume":"71","author":[{"given":"Adane S.","family":"Nigatu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravanthi","family":"Vupputuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.02.015_bib0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 \u2013 an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J Gene Med"},{"key":"10.1016\/j.biopha.2015.02.015_bib0225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","article-title":"Adenovirus vectors for gene delivery","volume":"10","author":"Benihoud","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.biopha.2015.02.015_bib0230","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/jvi.62.7.2321-2328.1988","article-title":"Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms","volume":"62","author":"Wohlfart","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.biopha.2015.02.015_bib0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0240","doi-asserted-by":"crossref","first-page":"11377","DOI":"10.1073\/pnas.95.19.11377","article-title":"Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy","volume":"95","author":"Kafri","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biopha.2015.02.015_bib0245","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopha.2015.02.015_bib0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","article-title":"Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses","volume":"11","author":"Mok","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0255","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O\u2019Riordan","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.gt.3301389","article-title":"Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies","volume":"8","author":"Fisher","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.mt.6300306","article-title":"Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies","volume":"16","author":"Wortmann","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coph.2006.04.004","article-title":"Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery","volume":"6","author":"Mae","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biopha.2015.02.015_bib0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-008-9071-2","article-title":"Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment","volume":"11","author":"El-Sayed","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.biopha.2015.02.015_bib0280","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1042\/BST0350807","article-title":"Cell-penetrating-peptide-mediated siRNA lung delivery","volume":"35","author":"Moschos","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.biopha.2015.02.015_bib0285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.lfs.2008.09.022","article-title":"Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency","volume":"83","author":"Yoshioka","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.biopha.2015.02.015_bib0290","doi-asserted-by":"crossref","DOI":"10.1002\/jps.23556","article-title":"Evaluation of cell-penetrating peptide\/adenovirus particles for transduction of CAR-negative cells","author":"Nigatu","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biopha.2015.02.015_bib0295","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2144\/000112152","article-title":"Utility of cell-permeable peptides for enhancement of virus-mediated gene transfer to human tumor cells","volume":"40","author":"Lehmusvaara","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.biopha.2015.02.015_bib0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nm835","article-title":"Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo","volume":"9","author":"Gratton","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biopha.2015.02.015_bib0305","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2015.02.015_bib0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S1525-0016(03)00166-7","article-title":"HIV vector production mediated by Rev protein transduction","volume":"8","author":"Kowolik","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0003-2697(86)90520-8","article-title":"A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol","volume":"154","author":"Stocks","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biopha.2015.02.015_bib0320","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biopha.2015.02.015_bib0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0076-6879(83)91010-8","article-title":"Reassessment of Ellman's reagent","volume":"91","author":"Riddles","year":"1983","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biopha.2015.02.015_bib0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652307780859062","article-title":"Current advances and future challenges in Adenoviral vector biology and targeting","volume":"7","author":"Campos","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.biopha.2015.02.015_bib0335","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.peptides.2009.05.017","article-title":"Transduction of adenovirus vectors modified with cell-penetrating peptides","volume":"30","author":"Eto","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2015.02.015_bib0340","first-page":"255","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems \u2013 a review (Part 1)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.biopha.2015.02.015_bib0345","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems \u2013 a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.biopha.2015.02.015_bib0350","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbamem.2006.02.006","article-title":"A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction","volume":"1758","author":"Gros","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopha.2015.02.015_bib0355","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/nar\/gkg160","article-title":"Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation","volume":"31","author":"Dom","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2015.02.015_bib0360","doi-asserted-by":"crossref","first-page":"33957","DOI":"10.1074\/jbc.M109.056309","article-title":"Translocation and endocytosis for cell-penetrating peptide internalization","volume":"284","author":"Jiao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2015.02.015_bib0365","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2015.02.015_bib0370","doi-asserted-by":"crossref","first-page":"31192","DOI":"10.1074\/jbc.M303938200","article-title":"Studies on the internalization mechanism of cationic cell-penetrating peptides","volume":"278","author":"Drin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2015.02.015_bib0375","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0854.2007.00572.x","article-title":"A comprehensive model for the cellular uptake of cationic cell-penetrating peptides","volume":"8","author":"Duchardt","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.biopha.2015.02.015_bib0380","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-penetrating peptides: mechanism and kinetics of cargo delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biopha.2015.02.015_bib0385","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-007-9303-7","article-title":"Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.biopha.2015.02.015_bib0390","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/bi0491604","article-title":"The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence","volume":"44","author":"Ziegler","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2015.02.015_bib0395","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00018-005-5109-0","article-title":"Cell-penetrating peptides: tools for intracellular delivery of therapeutics","volume":"62","author":"Deshayes","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biopha.2015.02.015_bib0400","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S0033583505004014","article-title":"Cell-penetrating peptides: [corrected] from inception to application","volume":"37","author":"Magzoub","year":"2004","journal-title":"Q Rev Biophys"},{"key":"10.1016\/j.biopha.2015.02.015_bib0405","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/j.1460-2075.1989.tb08528.x","article-title":"Adenovirus polypeptide-Ix revealed as capsid cement by difference images from electron-microscopy and crystallography","volume":"8","author":"Furcinitti","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.biopha.2015.02.015_bib0410","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.biopha.2015.02.015_bib0415","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.chom.2009.11.006","article-title":"Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit","volume":"6","author":"Bremner","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2015.02.015_bib0420","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1021\/ja710798b","article-title":"Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells","volume":"130","author":"Lee","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.biopha.2015.02.015_bib0425","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/ac060041z","article-title":"Determining the conformation of thiolated poly(ethylene glycol) on Au nanoshells by surface-enhanced Raman scattering spectroscopic assay","volume":"78","author":"Levin","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.biopha.2015.02.015_bib0430","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for imaging and therapy","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine (Lond)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:57:02Z","timestamp":1760093822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":43,"alternative-id":["S0753332215000645"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.02.015","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}